ABSTRACT: Daily activities subject our tendons to accumulation of sub-rupture fatigue injury which can lead to tendon rupture. Consequently, tendinopathies account for over 30% of musculoskeletal consultations. We adopted a multidisciplinary approach to determine the role of the extracellular matrix (ECM) in the pathogenesis of tendinopathy and impaired healing of ruptured tendons. We have been investigating three main areas: (i) the pathogenesis of tendon degeneration; (ii) approaches to promoting remodeling of sub-rupture fatigue injuries; and the (iii) role of the ECM in promoting scarless tendon healing. In this Kappa Delta Young Investigator award paper, we describe the key discoveries made in each of our three research areas of focus. Briefly, we discovered that sub-rupture fatigue damage can accumulate from just one bout of fatigue loading. Furthermore, any attempt to repair the fatigue damage diminishes as the severity of induced damage increases. We have utilized exercise to develop animal models of exercise-led degeneration and exercise-led repair of sub-rupture fatigue damage injuries, wherein underlying mechanisms can be uncovered, thereby overcoming a major hurdle to development of therapeutics. Since damage accumulation ultimately leads to rupture that is characterized by formation of a mechanically inferior scar, we have used the MRL/MpJ mouse to evaluate the role of the systemic environment and the local tendon environment in driving regeneration to identify new therapeutic pathways to promote scarless healing. Our data suggests that the therapeutic potential of the MRL/MpJ provisional ECM should be further explored as it may harness biological and structural mechanisms to promote scarless healing. ß
Tendons regularly transmit large forces from muscle to bone to allow joint motion with stability. 1 Despite the optimization of the structure and composition of the tendon to accommodate its demanding loading function, repetitive loads that are common to daily activities promote accumulation of sub-rupture damage which may ultimately progress to rupture. Consequently, tendinopathies and tendon tears account for over 30% of all musculoskeletal consultations. 2 Healing of tendon tears is limited, with small tears often propagating into larger, less manageable tears 3, 4 leading to poor post-surgical outcome. 5 Thus, progress in therapeutics requires mechanistic understanding so as to effectively intervene at multiple stages of the disease, namely, (i) early at onset of sub-rupture damage so as to halt the progression of tendinopathy and (ii) after onset of tendon ruptures so as to promote scarless healing and improve surgical outcome.
In addition to impairing the macroscopic mechanical properties of the tendon, 6 damage to the tendon structure, or extracellular matrix (ECM), impacts the biomechanical environment of the resident tendon cells (tenocytes), 7 orchestrating a biological response that leads to ineffective repair of accumulated subrupture ECM damage 8 and impaired healing of tendon ruptures. 9 Consequently, the structure and composition of the ECM is an essential component of tendon homeostasis (maintained equilibrium), degeneration, and repair. 10 The ECM is a conglomerate of several fibrillar and non-fibrillar components, including collagens and elastic fibers along with viscoelastic hyaluronan and glycosaminoglycans (GAGs). Each tissue requires a unique relative contribution of different ECM components to achieve its specific biomechanical demands. For instance, the high composition of hierarchical 11 collagen (Col) I 12 is essential to the ability of the tendon to bear tensile loads and is compromised during injury. 13 In addition to providing mechanical support for the cells, 14 the ECM sequesters cytokines and growth factors for release when needed. 15 We expect that accumulation of fatigue damage or overt tendon rupture alters the structure of the tendon thereby modulating the cellular micro-mechanical environment and the resulting cellular responses. Consequently, we have adopted a multidisciplinary approach that incorporates biomechanics, biology, and imaging to determine the structural and regulatory role of the tendon ECM in the pathogenesis of tendinopathy and impaired healing of ruptured tendons. We are utilizing animal models to investigate (i) the pathogenesis of tendon degeneration; and (ii) approaches to promoting remodeling of sub-rupture fatigue damage injuries. Since accumulation of sub-rupture damage ultimately leads to ruptured tendons which heal with mechanically inferior scarformation, we are also investigating (iii) the role of the ECM in promoting scarless tendon healing. Our key findings in each of the aforementioned three areas are summarized below.
The Pathogenesis of Tendinopathy
As a first step toward exploring the role of the ECM in progression and repair of tendon damage, we have developed a rat 8, 16, 17 model of sub-rupture fatigue damage accumulation wherein we can investigate the early pathogenesis of tendinopathy. Briefly, under IACUC approval, 9-month old retired breeder female Sprague-dawley (SD) rats are anesthetized with isoflurane (2-3% by volume, 0.4 L/min) and their left patellar tendons are surgically exposed for fatigue loading. 8, 16, 17 Under aseptic conditions, the tibia is clamped to fix the knee at $30˚flexion. The patella is gripped with another clamp and then connected to a 50-lb load cell and actuator of a servo-hydraulic loading system, allowing loading of the tendon without direct contact with the tendon (Fig. 1A) . Fatigue loading can then be applied to the patellar tendon in a controlled and reproducible manner while providing flexibility to modify any of the loading input parameters, such as magnitude, frequency, or number of cycles (Fig. 1B) . After loading, the clamps are removed and the skin incisions are sutured with 6-0 prolene. Analgesia (Buprenex) is administered and the animal resumes cage activity. All rats are housed in pairs in standard cages. We have also expanded our model of sub-rupture fatigue damage accumulation for use with mice to allow future studies to utilize inbred mouse strains and genetic mutants in our investigations of the pathogenesis and treatment of tendinopathies. 18 In the studies discussed in this manuscript, fatigue loading was conducted by cycling to 40% of ultimate load at a frequency of 1 Hz, which is a frequency that is characteristic of physiological daily activities. 19 The load levels utilized in our model ($40% of ultimate load) are characteristic of strenuous activities commonly experienced by athletes. 20, 21 The key lessons learned on the pathogenesis of tendinopathy are outlined below.
Lessons on Fatigue Damage Accumulation
Damage Can Begin to Accumulate Even From Just One Bout of Sub-Rupture Fatigue Loading While tendon failure is believed to result from a process wherein accumulation of damage outpaces any attempt to repair, our finding that just one bout of moderate level cyclic fatigue loading (7, 200 cycles: 2 h of intense exercise) leads to non-recoverable structural damage and loss in mechanical function was highly surprising. 22, 23 This finding suggests that a tendon from a sedentary individual could accumulate significant sub-rupture damage from one strenuous experience that is characterized by repetitive loading. Furthermore, characterization of the progression in fatigue life of the tendon during cyclic loading showed that the tendon has a unique response molecularly, mechanically, and structurally that is distinct from laceration injuries 16 or very low levels of cyclic loading (representative of exercise), 24 and changes with different amounts of induced fatigue damage. 8, 24, 25 We showed that low, moderate, and high level fatigue loading is correlated with progression in severity of structural damage (Fig. 2) . 16 More specifically, aligned collagen fibers in control, healthy tendons, become kinked as an early manifestation of damage. Further fatigue loading leads to widening of the inter fiber space that ultimately progresses to rupture. These findings demonstrate that accumulation of damage manifests as increasing severities of sub-rupture collagen matrix damage.
Induced Sub-Rupture Damage Does Not Innately Remodel We have also shown that applying one bout of moderate level fatigue loading (comparable to an intense bout of exercise by an untrained adult in their middle 20's 26 ) leads to an immediate 20% stiffness loss 22, 23 that is not recoverable out to at least 10-weeks. 22, 23, 27 It is important to note that a 20% stiffness loss is physiologically significant as it is characteristic of clinical patellar and Achilles tendinopathy in humans. 28, 29 Similarly the initial increase in damage area fraction (DAF), the fraction of the tendon that is structurally damaged, was sustained out to 8 weeks. 30 In addition, while one bout of sub-rupture injury is not sufficient to lead to measurable changes in gait initially after injury, our recent findings suggest that measurable changes develop over time. Taken together, our findings suggest that early onset and sustained structural and mechanical changes subject the tendon to an increasing risk of accumulating further injury.
The Severity of Initial Damage That Is Induced Is Correlated With a Diminished Attempt to Repair the Damage Our in vivo model of sub-rupture fatigue damage accumulation allows for accurate control of the loading applied to the tendon providing improvement over existing models. However, variability among tendons (e.g., size and strength) could result in varying amounts of induced damage for the same fatigue loading protocol. Therefore, we evaluated whether non-recoverable changes in mechanical parameters immediately after fatigue loading could be indicative of the amount of damage induced and can subsequently be used to interpret the mechanical and molecular response of the tendon at a later timepoint. 17 Accordingly, we calculated non-recoverable changes in initial mechanical parameters from our fatigue loading protocol by comparing their values in the last 10 cycles from non-damaging cyclic diagnostic tests applied before and after fatigue loading (Fig. 1B) . 17 More specifically, non-recoverable hysteresis loss, measures characterizing the toe region, stiffness of the loading and unloading portions of loaddisplacement curves, and tendon elongation were calculated and compared between diagnostic tests. We identified several indices of damage, including elongation, hysteresis loss, and decrease in loading stiffness and increase in unloading stiffness of the loaddisplacement curve.
Evaluating the molecular 8 and mechanical 17 response of the tendon 7-days post fatigue loading in the context of these initial indices of damage highlighted new relationships that were not discernible from striating the data strictly in the context of the applied number of fatigue loading cycles. For instance, significant correlations were found between initial nonrecoverable hysteresis loss and the 7-days post fatigue loading stiffness. 17 Furthermore, the expression of several genes that are suggestive of remodeling, namely Col I, Col III, Col V, Col XII, matrix metalloproteinase (MMP)-2, MMP-3, MMP-13, tissue inhibitor of metalloproteinases (TIMP)-1, TIMP-2, and TIMP-3, were negatively correlated with the amount of damage induced. 8 These findings motivated evaluation of apoptosis since a decrease in the population of cells that can repair the damage could be a mechanism that drives this observed "shut down" in molecular response. 31 Apoptosis, or cell death, is a hallmark of end stage tendinopathy. However, it remains unknown (i) whether apoptosis is modulated with onset of fatigue injury and (ii) what the role of apoptosis is in the progression of fatigue damage. Thus, we assessed the relationship between initial induced damage and the resulting apoptotic activity. 31 We found that apoptotic activity was increased after fatigue loading in a manner that was correlated with the amount of damage induced. 31 Our findings suggested that modulation of apoptosis, whether directly by pharmaceutical inhibitors or indirectly by prompting modification of the fatal cellular environment, would increase the population of cells available to repair the damage. Most notably, these studies showed that fatigue injuries are particularly hazardous to the tendon because they prompt a muted and ineffective biological response.
Promoting Repair of Sub-Rupture Fatigue Damage Injuries
Our findings suggest that excessive apoptosis is central to the impaired capacity of fatigue damaged tendon to remodel. Consequently, we have evaluated the role of apoptosis on the impaired ability of degenerated tendons to repair or heal. Pharmaceutical inhibitors of apoptosis were utilized to determine if cells in damaged regions that may typically undergo apoptosis can be prompted to repair the damaged ECM. In addition, since physiological loading can improve tendon homoeostasis and resistance to injury, physiological exercise was applied before or after induction of fatigue damage to prompt repair of these otherwise inert injuries. The key lessons learned on promoting remodeling of fatigue damaged tendons are outlined below.
Lessons on Remodeling of Fatigue Injuries

Pharmaceutical Inhibition of Apoptosis Promotes Further Degeneration of Fatigue Damaged Tendons
Pharmaceutical inhibition of apoptosis, using quinolylvalyl-O-methylaspartyl-[-2, 6-difluorophenoxy]-methyl ketone (Q-VD-OPh) (SM Biochemicals LLC, Anaheim, CA), a pan-caspase inhibitor, was used to evaluate (i) whether apoptosis could be inhibited after fatigue damage and (ii) whether its inhibition could lead to production of ECM proteins that are essential for remodeling and stabilization of the micromechanical environment of the cells. 32 Retired breeder female SD rats (9-month old) received 2 or 5 days of systemic Q-VD-OPh or dimethyl sulfoxide (DMSO) carrier control injections starting immediately prior to fatigue loading. Caspase-3 staining, indicative of apoptosis, was assessed at sacrifice at 7 and 14 days post fatigue loading. Systemic pan-caspase inhibition for 2 days was ineffective but inhibition for 5 days led to an increase in population of live cells. 32 Further evaluation of the 5 day group, wherein apoptosis was effectively modulated, generally showed a correlated increase in the population of cells that are producing ECM and pericellular matrix (PCM) proteins albeit in conjunction with an increase in oxidative stress markers. 32 Surprisingly, pharmaceutical inhibition of apoptosis ultimately led to exacerbation of damage of fatigue damaged tendons as indicated by further compromise in mechanical properties. 32 While inhibition of apoptosis may still be an effective approach to promoting repair of fatigue damaged tendons, a different approach, wherein cell survival is the outcome of a modulated micro-environment of the cells, should be considered. 28, 33 We therefore set out to determine whether physiological exercise can be used as a therapeutic. 34 Since the duration and the time of initiation of exercise after induction of fatigue damage injury is expected to be integral to the response of the tendon, we evaluated the effect of a 6-week, 30 min/ day, or 60 min/day treadmill running protocol that was initiated 1-day or 14-days after fatigue loading in 9-month-old retired breeder female SD rats. We chose the 14-day timepoint since it coincides with the return to baseline of the molecular response and apoptotic activity after a peak at 7 days. As such, we expected that there could be a larger population of live cells that can respond to the exercise at 14-days than at 1-day. Furthermore, these two timepoints of initiation of exercise represent two common, clinically relevant patient populations: (i) A patient who engages in one bout of a strenuous damaging activity but continues a regimen of physiological exercise starting the following day; (ii) A patient who engages in one bout of a strenuous damaging activity but rests for some time (14-days) before initiating exercise.
Our results showed that there was no difference between the effect of a short (30 min/day) and long (60 min/day) bout of exercise. 34 Initiating exercise 14-days after fatigue loading led to remodeling of ECM damage in the midsubstance (Fig. 3 ) and insertion. It is important to note that the macroscopic mechanical properties of the fatigue damaged tendon are similar at these two timepoints of initiation of exercise, 22, 23 suggesting that the difference between a degenerative versus a reparative outcome from physiological exercise is driven by changes in the cellular environment. Most importantly, this study established animal models for exercise-led remodeling and exercise-led degeneration of fatigue damaged tendons. By generating these two contrasting animal models, we can unravel the mechanisms that drive the response of fatigue damaged tendons to conservative treatment.
Exercise-Led Remodeling of Fatigue Damaged Tendons Is Associated With Decreased Apoptosis and an Increase in Population of Myofibroblasts
We evaluated the biological, structural, and mechanical response of fatigue damaged tendons to exerciseled remodeling. 27 Patellar tendons of 9-month old retired breeder female SD rats were fatigue loaded for Figure 3 . DAF for exercise-led remodeling and degeneration. Initiation of exercise 1-day after fatigue loading led to an increase in DAF. Initiation of exercise 2-weeks after fatigue loading led to a decrease in DAF. "
Ã " above bars denotes p < 0.05. 500 or 7,200 cycles. At 2-weeks after induction of fatigue injury, rats began an exercise regimen that consisted of running for 5 days/week at 17 m/min for 30 min/day. Animals were sacrificed 4-or 10-weeks after initial fatigue loading injury. At 10-weeks, exercise post fatigue loading increased stiffness (Fig. 4A) , providing further evidence that a delayed start of exercise after fatigue injury leads to effective remodeling. 27 At 4-weeks, exercise reduced apoptosis (caspase-3) (Fig. 4B) , aggrecan, and DAF, suggesting that inhibition of apoptosis may be mechanistically implicated in the ensuing restoration of mechanical properties. 27 Next we identified the biological and cellular changes that could motivate a mechanistic hypothesis for exercise-led remodeling of fatigue damaged tendons. Col VI was evaluated since this PCM protein is modulated when the micro-mechanical environment 22 is altered to protect cells from apoptosis. 35, 36 Myofibroblasts were evaluated because they exhibit the capacity to tension damage kinks and increase tissue stiffness. Transforming Growth Factor-b (TGF-b), a key activator of myofibroblasts, was evaluated using immunohistochemistry for downstream phosphorylated SMAD 2/3. In addition, fibrillin, an ECM protein that modulates availability of TGF-b was also evaluated. Integrin a5 was evaluated because of its role in allowing the cells to withstand higher loads which was expected in the context of exercise. 37 Lastly, integrin av was evaluated because of its role in activation of myofibroblasts. 38, 39 In comparison to non-exercised fatigue damaged tendons, exercise-led remodeling was associated with increase in myofibroblasts (a smooth muscle actin [aSMA]) ( Fig. 4C and 4D ), pSMAD 2/3, and fibrillin. 27 In addition, exercise decreased integrin aV and increased integrin a5 in fatigue damaged tendons. 27 Data suggests that a decrease in apoptosis and an increase in population of myofibroblasts may be integral to remodeling of fatigue damaged tendons. This data suggests that an increase in population of myofibroblasts and a decrease in apoptosis are integral to exercise-led remodeling of fatigue damaged tendons, and suggests that integrin a5, an integrin that is indirectly associated with activation of myofibroblasts, may be mechanistically implicated.
Our work investigating the onset and pathogenesis of tendinopathy has shown that fatigue damage injuries do not innately remodel or repair. Exercise can lead to remodeling post injury and protect the tendon from accumulating new injury. However, the timing and duration of exercise must be critically considered. Our data has identified several mechanisms by which exercise could lead to remodeling, thereby opening new avenues for diagnostics to help guide the timing of exercise as therapeutic.
The Role of the Structure and Composition of the ECM in Driving Scarless Healing Ruptured tendons do not effectively heal and inferior scar tissue substitutes for healthy tendon tissue. Promoting scarless tendon healing would significantly improve surgical outcome or eliminate the need for surgical repair altogether. Therapeutics to promote improved tendon healing have been largely ineffective due to scarcity of knowledge regarding their role in promoting scarless tendon healing. The discovery that adult Murphy Roths Large (MRL/MpJ) mice exhibit a regenerative capacity has distinguished this mouse as an exciting model to investigate mechanisms that underlie adult regenerative healing. 29 Accordingly, we have been utilizing the MRL/MpJ mouse as a model of scarless tendon healing overcoming a major hurdle to the development of effective therapeutics by elucidating the biological pathways that lead to effective tendon healing.
Interestingly, the regenerative capacity of MRL/ MpJ mice has been hypothesized to be driven by both systemic and tissue-specific factors since the discovery that their through-and-through ear punches healed without scar. 40 On the systemic scale, MRL/MpJ mice exhibit a dampened inflammatory response. Similar to EFFECTIVE TENDON HEALING AND REMODELING scar-mediated C57BL/6 (B6) healing, MRL/MpJ regenerative healing initiates with a conventional infiltration of inflammatory cells 41 but includes formation of a blastema or a cellular structure of progenitor cells that are ready to form new tissue. 42 The potential role of the immunocompromised environment of the MRL/ MpJ mouse in driving regeneration is supported by the fact that only full (and not partial) thickness injuries in cartilage, wherein circulating inflammatory cytokines from the blood readily infiltrate the damaged region, exhibit regenerative healing. 43 On the local tissue scale, the basement membrane that is typically maintained throughout the wound healing process in non-regenerative healing is broken down during regenerative healing in MRL/MpJ mice 44 through the activity of several MMPs, implicating an essential role of MMPs in this context of regenerative healing. 41 More recently, the growth factor-rich cellfree ECM that is synthesized from cells extracted from the blastema of healing ear punches in MRL/MpJ mice has been found to promote cell proliferation, migration, and scarless healing of dorsal cutaneous wounds in B6 mice, 45 further implicating the MRL/MpJ ECM in driving regeneration. Interestingly, the regenerative capacity of MRL/MpJ does not extend to every tissue, and significant but weak correlations have been found between their capacity to regenerate ear punches and their capacity to regenerate articular cartilage. 43 Shared characteristics between tissues that regenerate in MRL/MpJ mice suggest that the improved healing ability of these mice is either systemic or due to biological mechanisms that are common between tissues. In contrast the limitation of MRL/MpJ mice to regenerate all tissues supports that their regenerative ability is driven by the specific characteristics of the healing tissue.
The provisional ECM that is deposited during healing plays an essential structural and regulatory role during tissue healing.
14,46 Preliminarily, we have found improved structural healing in a tendon laceration injuries, as indicated by restoration of organized matrix 6 weeks following injury as well as improved tendon repair following sub-rupture fatigue injury, as indicated by recovery of stiffness 8 weeks following injury, in MRL/MpJ mice. 29 This data supports a tissue driven contribution to regeneration since this injury elicits a minimal systemic response that is not characterized by overt inflammation. While effective healing in MRL/MpJ is likely the result of cooperative roles between the systemic environment and the environment of the local tissue, we expect that the local tissue environment is integral to driving regeneration.
Consequently, we are interrogating the systemic and local factors that contribute to synthesis of MRL/MpJ's unique provisional ECM and elucidating the role of this provisional ECM in modulating the cellular response. We are exploring the therapeutic potential of the provisional ECM derived from MRL/MpJ healing tendons to promote scarless healing in scar-mediated B6 tendons. We are utilizing novel microsurgical techniques and organ culture systems to uncouple the contribution of the systemic environment and the tendon to scarless tendon healing. These foundational studies will inform development of therapeutic interventions by isolating the contributions of the tendon and the systemic environment to scarless tendon healing. The key lessons learned on characteristics and drivers of scarless tendon healing are outlined below.
Lessons on Promoting Scarless Healing of Ruptured Tendons
Following IACUC approval, 8-9-week-old male MRL/ MpJ and B6 mice were subjected to left unilateral ear punch for 4 weeks and left patellar punch for 1 or 4 weeks. 47 All mice underwent ear punch injury at Day 0 and received a full thickness excisional patellar tendon punch that was allowed to heal for either 1 or 4 weeks so that all mice were sacrificed at the end of the 4 week study period (Table 1 ). Blood samples were collected 24 h following ear and tendon punch, and ear punches were imaged at D0 and 4W. Histology and ELISA were used to evaluate tendon healing and the associated modulation of key growth factors. In addition, serological analysis using multiplex ELISA to compare 14 different markers that are characteristic of systemic inflammation within strains and in response to different injuries was conducted. All mice were group housed (5 mice/cage) in standard cages.
Regenerative Tendon Healing Is Characterized by Early Ecm and Cell Alignment
We 47 found that healing MRL/MpJ tendons 8 exhibited a significantly larger area of aligned ECM, and a significantly smaller area of unaligned ECM compared to scar-mediated healer B6 tendons, with differences being notable as early as 1-week after laceration (Fig. 5) . 47 Ongoing studies are identifying the key proteins that are responsible for this distinctly different early regenerative ECM. Consequently, we have established methods to evaluate 3 dimensional (3D) cell and ECM strains that can be used with whole tendon tissue in order to quantify the effect of the higher stiffness of healing MRL/MpJ tendon on the deformations experienced by the cells and thereby the biological outcome. 48 A custom Matlab program was developed to calculate 3D cell and matrix strain (Fig. 6 ). This algorithm accounts for out-of-plane motion in a 3D volume, and these considerations are necessary in damaged and diseased tendons. Cellular deformation is calculated by comparing the changes in the ratio of the longest and smallest axis (aspect ratio) between loaded and unloaded cells. Our recent studies have shown that these methods are extendable for use with rat, which greatly expands the utility of these methods ( Fig. 6D and 6E ).
Regenerative Tendon Healing Is Characterized by Distinct Levels of Key Growth Factors Studies 47 of scar-mediated canonical tendon healing have led to identification of several growth factors that are thought to be integral to the regenerative healing response despite their potential contribution to the scar-mediated healing outcome. We sought to evaluate some of these growth factors in the context of a scarless tendon healing response to provide critical insight into their distinct roles in regenerative versus scar-mediated healing outcomes. We found that healing MRL/MpJ tendons modulated key growth factors, TGF-b, platelet-derived growth factor (PDGF), and basic fibroblast growth factor (bFGF) differently than scar-mediated healer B6 tendons. 47 Investigating the network of growth factors and ECM structural proteins that promote scarless tendon healing allows us to utilize a disease-centered network approach to identify specific integral pathways while overcoming the limitations associated with investigation of individual pathways in isolation. Our data supports the notion that regenerative healing will be achieved through modulation of the healing environment and not just through modulation of one growth factor. healing varied in MRL/MpJ mice. Cluster analysis revealed three distinct sub-populations with varying degrees of healing, henceforth referred to as "superhealer," "healer," and "non-healer." 47 While distinctly superior to the healing of control B6 mice, the variation in MRL/MpJ ear punch healing enables correlations to be made within the strain.
Lack of Correlations
We found that the extent of healing of MRL/MpJ tendon injuries does not correlate with the capacity of each mouse to heal its ear injury. We evaluated systemic levels of 14 inflammatory cytokines in association with both, ear and tendon injuries. Our findings that the systemic responses to tendon injury and ear cartilage injury did not differ in MRL/MpJ suggests that the uncorrelated healing responses of these tissues result despite a similar systemic response (Fig. 7) . 47 In addition, the systemic response in MRL/ MpJ due to tendon or ear injury differed from that of B6 injuries. To further interrogate these findings, ongoing studies are currently evaluating the healing capacity of regenerative MRL/MpJ tendons when placed in the scar-mediated healing environment of the B6 mouse.
CONCLUSIONS
Most commonly, tendon injuries are chronic, resulting from cumulative "microtrauma," degeneration (tendinosis), and ultimately tendon failure. 49 Clinically, surgical intervention for management of tendon tears is indicated only after failure of non-surgical approaches. 50, 51 The response of the fatigue damaged tendon to exercise as a therapeutic measure after damage is largely unknown. This makes it difficult for the clinician to have any scientific basis for treatment recommendations. In addition, since tendinopathies ultimately progress to ruptures, the limited success of surgical repair and high rates of retear 52, 53 have motivated our studies of scarless tendon healing using the MRL/MpJ mouse. While most of our work has focused on the basic mechanisms of regeneration of large tendon defects (biopsy punch), ongoing studies are evaluating the regenerative capacity of MRL/MpJ in more clinically applicable rotator cuff injuries. 54 Furthermore, our ongoing studies that are isolating the contributions of the innate tendon and the systemic environment to scarless tendon healing will identify new therapeutic pathways to promote scarless healing. For instance, the potential utility of MRL/ MpJ's provisional ECM as a therapeutic intervention that harnesses the biological and structural mechanisms that lead to scarless tendon healing could be highly impactful for the field of tendon tissue engineering.
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